Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it?

Vladimir Trkulja

Published in: British journal of clinical pharmacology (2022)

Keyphrases

rheumatoid arthritis
sars cov
cardiovascular events
juvenile idiopathic arthritis
early onset
rheumatoid arthritis patients
risk factors
coronary artery disease
cardiovascular disease
disease activity
drug induced
systemic lupus erythematosus